3Radomski MW,Palmer RM,Moncada S.An L-arginine nitric oxide pathway present in human platelets regulates aggregation[J].Proc Natl Acad Sci USA,1990,87(13):5193-5197.
4Pronai L,Ichimori K,Nozaki H,et al.Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies [J].Eur J Biochem,1991,202(3):923-930.
5Metha JH,Chen LY,Kone BC,et al.Identification of constitutive and inducible forms of nitric oxide synthase in human platelets[J].J Lab Clin Med,1995,125(3):370-377.
6Sase K,Michel T.Expression of constitutive nitric oxide synthase in human blood platelets [J].Life Sci,1995,57(22):2049-2053.
7Chen LY,Mehta JL.Further evidence of the presence of constitutive and inducible nitrie oxide synthase iso forms in human platelets[J].J Cardiovas Pharmacol,1996,27(1):157-158.
8Anfossi G,Russo I,Massucco P,et al.L-arginine modulates aggregation and intracellular cyclie 3,5-guanosine monophosphate levels in human platelets:direct effect and interplay with antioxidative thiol agent[J].Thromb Res,1999,94(5):307-316.
9Freedman JE,Farhat JH,Losealzo J,et al.Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase Cdependent mechanism[J].Circulation,1996,94(10):2434-2440.
10Tanus-Santos JE,Desai M,Deak LR,et al.Effects of endothelial nitrie oxide synthase gene polymorphisms on platelet funetion,nitric oxide release,and interactions with estradiol[J].Pharmacogenetics,2002,12(5):407-413
